Purpose There are no evidence-based guidelines informing which patients with head and
neck cancer (HNC) require regular speech pathology (SP) support during radiation …

Purpose Optimal care suggests that all moderate-high risk head and neck (H&N) cancer
patients should receive speech pathology assessment, education and management when …

Purpose Dysphagia is a common and debilitating side effect for head and neck cancer
(HNC) patients undergoing radiotherapy (RT) with or without chemotherapy ([C] RT) and is …

Purpose Reports of acute treatment-related dysphagia and toxicities for patients with parotid
tumours or cutaneous head and neck cancer (HNC) are limited. This study aimed to …

Introduction This study examined knowledge and practices of speech pathologists (SP s)
and radiation therapists (RT s) regarding plan optimisation for head and neck cancer (HNC) …

Objective: Patient and treatment characteristics of patients with head and neck cancer
(HNSCC) were correlated with dysphagia scored on swallowing-videofluoroscopy (VFS) …

Background: Resource limitations affect the intensity of speech–language pathology (SLP)
dysphagia interventions for patients with head-and-neck cancer (HNC). The objective of the …

Current Treatment Options in Oncology human papillomavirus (HPV) vaccine and more
favourable prognosis of HPV-related cancers. Increased prevalence of HPV-positive …

We undertook a service evaluation to establish how oropharyngeal dysphagia is managed
in head and neck cancer patients receiving radiotherapy in the United Kingdom. A web …

Intensive, prophylactic swallowing therapy programs have been developed to improve
dysphagia outcomes for patients with head/neck cancer (HNC) receiving (chemo) …